MEIHUA INTERNATIONAL MEDICAL (MHUA) Stock Fundamental Analysis
NASDAQ:MHUA - Nasdaq - KYG5966G1082 - Common Stock - Currency: USD
Overall MHUA gets a fundamental rating of 5 out of 10. We evaluated MHUA against 187 industry peers in the Health Care Equipment & Supplies industry. While MHUA has a great health rating, its profitability is only average at the moment. MHUA has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
MHUA had positive earnings in the past year.
MHUA had a positive operating cash flow in the past year.
Each year in the past 5 years MHUA has been profitable.
In multiple years MHUA reported negative operating cash flow during the last 5 years.
1.2 Ratios
MHUA has a Return On Assets of 8.35%. This is amongst the best in the industry. MHUA outperforms 91.44% of its industry peers.
The Return On Equity of MHUA (9.79%) is better than 85.56% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.47%, MHUA belongs to the top of the industry, outperforming 91.44% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MHUA is in line with the industry average of 7.89%.
The 3 year average ROIC (6.66%) for MHUA is below the current ROIC(9.47%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 9.79% | ||
| ROIC | 9.47% |
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
1.3 Margins
MHUA has a better Profit Margin (10.94%) than 85.56% of its industry peers.
In the last couple of years the Profit Margin of MHUA has declined.
With an excellent Operating Margin value of 14.20%, MHUA belongs to the best of the industry, outperforming 83.42% of the companies in the same industry.
In the last couple of years the Operating Margin of MHUA has declined.
Looking at the Gross Margin, with a value of 34.08%, MHUA is doing worse than 72.19% of the companies in the same industry.
MHUA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.2% | ||
| PM (TTM) | 10.94% | ||
| GM | 34.08% |
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
2. Health
2.1 Basic Checks
MHUA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for MHUA has been increased compared to 1 year ago.
Compared to 5 years ago, MHUA has more shares outstanding
MHUA has about the same debt/assets ratio as last year.
2.2 Solvency
MHUA has an Altman-Z score of 3.07. This indicates that MHUA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MHUA (3.07) is better than 68.45% of its industry peers.
The Debt to FCF ratio of MHUA is 0.55, which is an excellent value as it means it would take MHUA, only 0.55 years of fcf income to pay off all of its debts.
MHUA has a Debt to FCF ratio of 0.55. This is amongst the best in the industry. MHUA outperforms 93.58% of its industry peers.
MHUA has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MHUA (0.05) is better than 63.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 3.07 |
ROIC/WACC1.43
WACC6.63%
2.3 Liquidity
A Current Ratio of 5.26 indicates that MHUA has no problem at all paying its short term obligations.
MHUA has a better Current ratio (5.26) than 77.01% of its industry peers.
A Quick Ratio of 5.21 indicates that MHUA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.21, MHUA belongs to the top of the industry, outperforming 80.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.26 | ||
| Quick Ratio | 5.21 |
3. Growth
3.1 Past
The earnings per share for MHUA have decreased strongly by -29.57% in the last year.
The earnings per share for MHUA have been decreasing by -13.75% on average. This is quite bad
The Revenue has decreased by -2.09% in the past year.
The Revenue has been growing slightly by 4.01% on average over the past years.
EPS 1Y (TTM)-29.57%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-18.41%
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-0.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 0.75, which indicates a rather cheap valuation of MHUA.
Compared to the rest of the industry, the Price/Earnings ratio of MHUA indicates a rather cheap valuation: MHUA is cheaper than 99.47% of the companies listed in the same industry.
MHUA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.75 | ||
| Fwd PE | N/A |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than MHUA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.9 | ||
| EV/EBITDA | -0.14 |
4.3 Compensation for Growth
MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for MHUA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.4098
0 (-0.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.06%
Inst Owner Change32.51%
Ins Owners49.95%
Ins Owner ChangeN/A
Market Cap13.07M
AnalystsN/A
Price TargetN/A
Short Float %0.09%
Short Ratio0.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.75 | ||
| Fwd PE | N/A | ||
| P/S | 0.09 | ||
| P/FCF | 0.9 | ||
| P/OCF | 0.89 | ||
| P/B | 0.08 | ||
| P/tB | 0.08 | ||
| EV/EBITDA | -0.14 |
EPS(TTM)0.55
EY134.21%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.45
FCFY110.94%
OCF(TTM)0.46
OCFY111.97%
SpS4.46
BVpS4.98
TBVpS4.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 9.79% | ||
| ROCE | 12.71% | ||
| ROIC | 9.47% | ||
| ROICexc | 10.48% | ||
| ROICexgc | 10.51% | ||
| OM | 14.2% | ||
| PM (TTM) | 10.94% | ||
| GM | 34.08% | ||
| FCFM | 10.2% |
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexcg growth 3Y-27.75%
ROICexcg growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score4
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 0.38 | ||
| Cap/Depr | 23.41% | ||
| Cap/Sales | 0.09% | ||
| Interest Coverage | 81.6 | ||
| Cash Conversion | 70.46% | ||
| Profit Quality | 93.21% | ||
| Current Ratio | 5.26 | ||
| Quick Ratio | 5.21 | ||
| Altman-Z | 3.07 |
F-Score4
WACC6.63%
ROIC/WACC1.43
Cap/Depr(3y)500.62%
Cap/Depr(5y)471.13%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.57%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-18.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-0.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.01%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%